Investment objective

To provide long-term capital growth by investing in equity securities of European companies in order to provide exposure to growth opportunities in the European economy and diversification benefits beyond North America.

Download fund details    Download fund commentary   

Fund details

Series
Currency
Fund code
MER * (%)
F CAD 35075 0.99%

Portfolio analysis As of Apr 30, 2025

98% 2%
Equity Fixed Income

Asset mix

Equity Sector Allocation
Financials25.4%
Industrials17.3%
Health Care14.4%
Consumer Staples9.4%
Materials8.1%
Consumer Discretionary7.8%
Information Technology6.9%
Utilities4.3%
Energy3.3%
Communication Services2.9%
Top 10 Holdings
% Assets
Allianz SE 3.6%
EssilorLuxottica SA 3.2%
Roche Holding AG 2.8%
ASML Holding NV 2.8%
Novo Nordisk A/S - Class B Shares 2.7%
Iberdrola SA 2.7%
Air Liquide SA 2.7%
London Stock Exchange Group PLC 2.6%
AstraZeneca PLC 2.6%
SAP SE 2.6%
Total % of Top 10 Holdings 28.3%

Geographic allocation

Region

Performance analysis

Growth of $10,000 since inception

Calendar returns

Trailing return

1 Mth 3 Mth 6 Mth 1 year 3 years 5 years 10 years Since Inception
3.8 0.4 8.4 6.2 12.0 9.7 6.3 5.0 Fund

Distribution ($)/unit

YTD* 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Total distributions 0.52 1.12 1.00 0.46 1.62 0.41 0.48 1.09 1.20 0.59 0.28
Interest --- 0.01 0.01 0.01 0.01 0.00 0.00 0.00 --- --- ---
Canadian dividends --- --- --- --- --- --- --- --- --- --- ---
Foreign dividends --- 0.56 0.59 0.43 0.34 0.30 0.51 0.55 0.39 0.34 0.32
Foreign taxes paid --- -0.07 -0.06 -0.04 -0.03 -0.03 -0.04 -0.06 -0.04 -0.03 -0.04
Capital gains --- 0.63 0.46 0.06 1.30 0.14 --- 0.60 0.85 0.28 ---
Return of capital --- --- --- --- --- --- --- --- --- --- ---

* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.